XG-104

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameXG-104
Drug Alias NameXG-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXigen Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXigen Sa
Active IndicationsN/A
Inactive IndicationsXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A